These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8014016)

  • 41. Occupational risk for renal cell carcinoma. A case-control study based on the New Zealand Cancer Registry.
    Delahunt B; Bethwaite PB; Nacey JN
    Br J Urol; 1995 May; 75(5):578-82. PubMed ID: 7613791
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Renal cell carcinoma rates compared with health status and behavior in the United States.
    Colli JL; Busby JE; Amling CL
    Urology; 2009 Feb; 73(2):431-6. PubMed ID: 18701146
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The demographics, histopathology and patterns of treatment of anal cancer in Connecticut: 1980-2000.
    Hatzaras I; Abir F; Kozol R; Sullivan P; Longo WE
    Conn Med; 2005 May; 69(5):261-5. PubMed ID: 16114640
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epidemiology of cancers of the kidney in an Australian population.
    Luke C; Sargent N; Pittman K; Price T; Roder D
    Asian Pac J Cancer Prev; 2011; 12(11):2893-9. PubMed ID: 22393960
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Adult renal neoplasms in the material of the Pathology Department of the Szeged University].
    Németh I; Sükösd F; Béli L; Kiss A; Pajor L; Mikó T; Iványi B
    Orv Hetil; 2005 Apr; 146(14):653-8. PubMed ID: 15889540
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence of renal cell carcinoma: a nation-wide survey in Japan, 2002.
    Marumo K; Kanayama H; Miyao N; Nakazawa H; Ozono S; Horie S; Nagamori S; Igarashi T; Hasegawa M; Kimura G; Nakao M; Nakamoto T; Naito S;
    Int J Urol; 2007 Jun; 14(6):479-82. PubMed ID: 17593088
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Time trends of non-Hodgkin's lymphoma: are they real? What do they mean?
    Holford TR; Zheng T; Mayne ST; McKay LA
    Cancer Res; 1992 Oct; 52(19 Suppl):5443s-5446s. PubMed ID: 1394151
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Secondary bladder cancer after upper tract urothelial carcinoma in the US population.
    Kates M; Badalato GM; Gupta M; McKiernan JM
    BJU Int; 2012 Nov; 110(9):1325-9. PubMed ID: 22564365
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genitourinary Malignancies in Transplant or Dialysis Patients: The Frequency of Two Newly Described 2016 World Health Organization Histopathologic Types.
    Billis A; Freitas LLL; Costa LBE; Barreto IS; Asato MA; Araujo KS; Losada DM; Herculiani AP; Tabosa GVBS; Zaidan BC; Oliveira GLP; Bastos LQA; Rocha RM
    Transplant Proc; 2017 Oct; 49(8):1783-1785. PubMed ID: 28923625
    [TBL] [Abstract][Full Text] [Related]  

  • 50. History of urinary tract infection and risk of renal cell carcinoma.
    Parker AS; Cerhan JR; Lynch CF; Leibovich BC; Cantor KP
    Am J Epidemiol; 2004 Jan; 159(1):42-8. PubMed ID: 14693658
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of smoking status on bladder tumor recurrence after radical nephroureterectomy for upper tract urothelial carcinoma.
    Hagiwara M; Kikuchi E; Tanaka N; Matsumoto K; Ide H; Miyajima A; Masuda T; Nakamura S; Oya M
    J Urol; 2013 Jun; 189(6):2062-8. PubMed ID: 23328579
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].
    Antonucci F; Camerin E; Feriani M; Nordio M; Piccoli A; Rossi B; Tessitore N
    G Ital Nefrol; 2009; 26 Suppl 48():S5-56. PubMed ID: 19927265
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Time period compared to birth cohort in Connecticut incidence rates for twenty-five malignant neoplasms.
    Roush GC; Schymura MJ; Holford TR; White C; Flannery JT
    J Natl Cancer Inst; 1985 Apr; 74(4):779-88. PubMed ID: 3857375
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Squamous cell carcinoma of the renal pelvis.
    Li MK; Cheung WL
    J Urol; 1987 Aug; 138(2):269-71. PubMed ID: 3599235
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Urologic cancer in Indonesia.
    Umbas R; Safriadi F; Mochtar CA; Djatisoesanto W; Hamid AR
    Jpn J Clin Oncol; 2015 Aug; 45(8):708-12. PubMed ID: 26085688
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Age-period-cohort modelling of large-bowel-cancer incidence by anatomic sub-site and sex in Connecticut.
    Dubrow R; Bernstein J; Holford TR
    Int J Cancer; 1993 Apr; 53(6):907-13. PubMed ID: 8473049
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Understanding Treatment Disconnect and Mortality Trends in Renal Cell Carcinoma Using Tumor Registry Data.
    Smaldone MC; Egleston B; Hollingsworth JM; Hollenbeck BK; Miller DC; Morgan TM; Kim SP; Malhotra A; Handorf E; Wong YN; Uzzo RG; Kutikov A
    Med Care; 2017 Apr; 55(4):398-404. PubMed ID: 27820596
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Renal collecting duct carcinoma. Report of a case with urinary cytologic findings.
    Mauri MF; Bonzanini M; Luciani L; Dalla Palma P
    Acta Cytol; 1994; 38(5):755-8. PubMed ID: 8091912
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Incidence of primary urethral carcinoma in the United States.
    Swartz MA; Porter MP; Lin DW; Weiss NS
    Urology; 2006 Dec; 68(6):1164-8. PubMed ID: 17141838
    [TBL] [Abstract][Full Text] [Related]  

  • 60. United States lung carcinoma incidence trends: declining for most histologic types among males, increasing among females.
    Travis WD; Lubin J; Ries L; Devesa S
    Cancer; 1996 Jun; 77(12):2464-70. PubMed ID: 8640694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.